Korro Bio (KRRO) Enterprise Value (2019 - 2026)
Korro Bio (KRRO) recorded Enterprise Value of $78.78 million in Q2 2026, up 276.4% from $20.93 million a year earlier and up 354.7% from the prior quarter.
Korro Bio (KRRO) Enterprise Value (2019 - 2026) Analysis & Trends
On a TTM basis, Korro Bio's Enterprise Value came in at -$202.82 million as of Jun 30, 2026; for FY2025, it was $276,535, down 99.9% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -91.4% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $230.9 million in FY2024, -$92.85 million in FY2023, -$6.13 million in FY2022 and $8.75 billion in FY2021 (-85.3%).
- Quarterly Enterprise Value has ranged from -$92.85 million in Q4 2023 to $12.05 billion in Q3 2021 over the past five years.
- On a year-over-year basis, Enterprise Value rose in two of the last seven quarters, with an average decline of 4.8%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 276.4% in Q2 2026, against a decline of 99.9% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $17.33 million (Q1 2026), $276,535 (Q4 2025) and $357.59 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Korro Bio | 145.73 Mn | -250.91 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.78 Mn |
| Mar 31, 2026 | 17.33 Mn |
| Dec 31, 2025 | 276,535.11 |
| Sep 30, 2025 | 357.59 Mn |
| Jun 30, 2025 | 20.93 Mn |
| Mar 31, 2025 | 48.51 Mn |
| Dec 31, 2024 | 230.90 Mn |
| Sep 30, 2024 | 174.42 Mn |
| Jun 30, 2024 | 156.88 Mn |
| Mar 31, 2024 | 583.22 Mn |
| Dec 31, 2023 | -92.85 Mn |
| Sep 30, 2023 | 641.41 Mn |
| Jun 30, 2023 | -41.69 Mn |
| Mar 31, 2023 | -59.82 Mn |
| Dec 31, 2022 | -6.13 Mn |
| Sep 30, 2022 | 3.06 Bn |
| Jun 30, 2022 | 2.51 Bn |
| Mar 31, 2022 | 3.59 Bn |
| Dec 31, 2021 | 8.75 Bn |
| Sep 30, 2021 | 12.05 Bn |
Korro Bio Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=KRRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();